BETWEEN:License, Distribution and Supply Agreement • June 29th, 2001 • Draxis Health Inc /Cn/ • Pharmaceutical preparations • Delaware
LICENSE, DISTRIBUTION AND SUPPLY AGREEMENTLicense, Distribution and Supply Agreement • August 8th, 2022 • PolyPid Ltd. • Surgical & medical instruments & apparatus • London
This License, Distribution and Supply Agreement (the “Agreement”) is entered into as of 2nd of August 2022 (the “Effective Date”), by and between PolyPid Ltd., a company existing under the laws of Israel, having offices at 18 Hasivim St. Petach Tikva 4917002, Israel (“PolyPid”), and Mercury Pharma Group Limited, under the trade name Advanz Pharma Holdings, a corporation organized under the laws of England, having its registered office at Capital House, 85 King William Street, London, EC4N 7BL, United Kingdom (“Partner”) and shall become effective on the Effective Date. PolyPid and Partner are sometimes referred to collectively herein as the “Parties” or singly as a “Party.”
